Isolated otolith dysfunction
09-09, 15:00–15:30 (Europe/Istanbul), Equilibrium 2

<p>Isolated otolith dysfunction Isolated otolith dysfunction</p>
<p></p>
Session Chair Session Chair
Speaker Speaker
<p>Prof. Dr. Bülent Satar was born in İskenderun, Türkiye, in 1967. He completed his primary, secondary, and high school education in the same city. He graduated from Gülhane Military Medical School in 1990 and subsequently completed his residency training in Otolaryngology – Head and Neck Surgery at Gülhane Military Medical Academy.</p> <p>He pursued postdoctoral fellowship training at the University of Michigan and University of California, San Francisco (UCSF), where he focused on otology, neurotology, ear disorders, and vestibular system diseases besides other ORL subspecialties. In addition, he visited the Department of Otolaryngology – Head and Neck Surgery at the Royal National Throat, Nose and Ear Hospital (London), Stanford University (Palo Alto) and Gruppo Otologico in Piacenza for further clinical and academic development.</p> <p>Prof. Satar became an Assistant Professor in 1998, Associate Professor in 2004, and Full Professor in 2010.</p> <p>Although his clinical practice covers the full spectrum of otolaryngology–head and neck surgery, he primarily specializes in a variety of otologic and vestibular disorders.</p> <p>Correspondence</p> <p>Prof. Dr. Bülent Satar SBÜ Gülhane Tıp Fakültesi KBB Anabilim Dalı 06018 Etlik, Ankara – Türkiye</p> <p>Mobile: +90 533 811 21 30 E-mail: [email protected]</p>
This speaker also appears in:
<p>I am a Professor of Clinical Otolaryngology, Director of the University of Miami Ear Institute, and Director of the ACGME-accredited Neurotology Fellowship Program. I hold two Board Certifications in Otolaryngology and Neurotology. Specific to this course, I am highly experienced in clinical and translational research in hearing loss and clinical research in genetic hearing loss. I am a cholesteatoma surgeon, have taught countless of surgical training courses both nationally and Internationally, and have carried out clinical studies on cholesteatoma outcomes in patients, both pediatric and adult subjects, from diverse backgrounds.</p>
This speaker also appears in: